Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome

Chinese Medical Journal

Volumn 123, Issue 22, 2010, Pages 3252-3257

  Lin, Dong Fang ^a,b   Yan, Shu Min ^c   Zhao, Yan ^a   Zhang, Wen ^a   Li, Meng Tao ^a   Zeng, Xiao Feng ^a   Zhang, Feng Chun ^a   Dong, Yi ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c Jishuitan Orthopaedic College of Tsinghua University   (China)

Author keywords

Prevalence; Prognosis; Sj gren's syndrome

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CAUSE OF DEATH; CHINESE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DENTAL CARIES; DISEASE DURATION; DRY EYE; ETHNIC DIFFERENCE; FATIGUE; FEMALE; FEVER; HUMAN; INTERSTITIAL LUNG DISEASE; KIDNEY DISEASE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MYOSITIS; ONSET AGE; PANCREAS DISEASE; PAROTID ENLARGEMENT; PERICARDIAL EFFUSION; PROGNOSIS; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SALIVARY GLAND BIOPSY; SJOEGREN SYNDROME; THYROID DISEASE; XEROPHTHALMIA; XEROSTOMIA;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 79251493781     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.22.015     Document Type: Article

References (25)

1. Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China. Rheumatol Int 2009; 29: 481-490.
2. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classication criteria for sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
3. Zhao Y, Dong Y, Guo XP, Tang FL. Clinical analysis of primary Sjögren's syndrome. Beijing Med (Chin) 1997; 19: 100-104.
4. García-Carrasco M, Ramos-Casals M, Rosas J, Pallarés L, Calvo-Alen J, Cervera R, et al. Primary sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 2002; 81: 270-280.
5. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary sjögren's syndrome. Semin Arthritis Rheum 2000; 29: 296-304.
6. Davidson BKS, Kelly CA, Griffiths ID. Primary sjögren's syndrome in the North East of England: a long-term follow-up study. Rheumatology 1999; 38: 245-253.
7. Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003. Rheumatology 2006; 45: 187-191.
8. Ramos-Casals M, Brito-Zeron P, Yague J, Akasbi M, Bautista R, Ruano M, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjögren's syndrome. Rheumatology 2005; 44: 89-94.
9. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006; 65: 796-803.
10. Westhoff G, Zink A. Epidemiology of primary Sjörgren's syndrome. Z Rheumatol 2010; 69: 41-49.
11. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J. Primary sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008; 87: 210-219.
12. Shi JH, Liu HR, Xu WB, Femg RE, Zhang ZH, Tian XL, et al. Pulmonary manifestations of Sjögren's Syndrome. Respiration 2009; 78: 377-386.
13. Vassiliou VA, Moyssakis I, Boki KA. Moutsopoulos HM. Is the heart affected in primary Sjögren's syndrome? An echocardiographic study. Clin Exp Rheumatol 2008; 26: 109-112.
14. Zhang ZL, Dong Y. Clinical and immunological characteristics of liver damage in Primary Sjögren's syndrome. Chin Rheumatol (Chin) 1998; 2: 92-96.
15. Wu HS, Song H, Huang YH, Huang XY. Primary Sjögren's syndrome liver damage. Chin Rheumatol (Chin) 2001; 5: 29-31.
16. Rueda JC, Duarte-Rey C, Casas N. Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with rituximab: report of a case and review of the literature. Rheumatol Int 2009; 29: 1481-1485.
17. Ren H, Wang WM, Chen XN, Zhang W, Pan XX, Wang XL, et al. Renal involvement and follow up of 130 patients with primary Sjögren's syndrome. J Rheumatol 2008; 35: 278-284.
18. Tang FL, Wang GS, Sun LR, Zhang R. Clinical analysis of primary Sjogren's syndrome associated with thyroiddysfunction. Chin Rheumatol 1998; 2: 71-74.
19. Tiemann M, Asbeck R, Wacker HH. Clonal B-cell reaction in Sjögren disease and Hashimoto autoimmune thyroiditis. Pathologe 1996; 17: 289-295.
20. E, Jacobsson LT. Relationship of sjögren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am 2008; 34: 935-947, viii-ix.
21. Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, et al. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum 2004; 50: 882-891.
22. Pan HF, Ye DQ, Wang Q, Li WX, Zhang N, Li XP, et al. Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjögren syndrome in China: a study of 542 patients. Clin Rheumatol 2008; 27: 339-343.
23. Xu D, Tian X, Zhang W, Liu B, Zhang FL. Sjögren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study. Lupus 2010; 19: 197-200.
24. Salliot C, Mouthon L, Ardizzone M, Sibilia J, Guillevin L, Gottenberg JE, et al. Sjögren's syndrome is associated with and not secondary to systemic sclerosis. Rheumatology (Oxford) 2007; 46: 321-326.
25. Zhang W, Feng S, Yan S, Zhao Y, Li M, Sun J, et al. Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort. Rheumatology (Oxford) 2010; 49: 571-577.